Skip to content

Bio-Rad Laboratories (BIO) — insider trading

Health Care · NYSE

Bio-Rad Laboratories (BIO) has 109 reported SEC Form 4 insider transactions in our data, including 2 open-market sales among the most recent 100 (latest 2026-09-06).

Recent Form 4 transactions

Showing the 100 most recent of 109 recorded transactions. See all on SEC EDGAR →

DateInsiderRoleTypeSharesPriceValueFiling
2026-09-06 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Option exercise / conversion (derivative) 1,152 — $0 Form 4
2026-09-06 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Shares withheld for taxes / exercise cost 485 $386.11 $187.3K Form 4
2026-09-06 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Option exercise / conversion 1,152 — $0 Form 4
2026-09-06 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Option exercise / conversion (derivative) 768 — $0 Form 4
2026-09-06 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Shares withheld for taxes / exercise cost 305 $386.11 $117.8K Form 4
2026-09-06 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Option exercise / conversion 768 — $0 Form 4
2026-09-06 EVRAN SEDAT Officer (EVP, Global Supply Chain) Option exercise / conversion (derivative) 864 — $0 Form 4
2026-09-06 EVRAN SEDAT Officer (EVP, Global Supply Chain) Shares withheld for taxes / exercise cost 277 $386.11 $107.0K Form 4
2026-09-06 EVRAN SEDAT Officer (EVP, Global Supply Chain) Option exercise / conversion 864 — $0 Form 4
2026-09-06 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Option exercise / conversion (derivative) 1,536 — $0 Form 4
2026-09-06 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Shares withheld for taxes / exercise cost 782 $386.11 $301.9K Form 4
2026-09-06 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Option exercise / conversion 1,536 — $0 Form 4
2026-09-06 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Option exercise / conversion (derivative) 3,455 — $0 Form 4
2026-09-06 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Shares withheld for taxes / exercise cost 1,854 $386.11 $715.8K Form 4
2026-09-06 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Option exercise / conversion 3,455 — $0 Form 4
2026-09-06 BARRY JAMES Officer (EVP, President, LSG) Option exercise / conversion (derivative) 1,056 — $0 Form 4
2026-09-06 BARRY JAMES Officer (EVP, President, LSG) Shares withheld for taxes / exercise cost 470 $386.11 $181.5K Form 4
2026-09-06 BARRY JAMES Officer (EVP, President, LSG) Option exercise / conversion 1,056 — $0 Form 4
2026-09-06 Allison Schwartz Director Option exercise / conversion (derivative) 92 — $0 Form 4
2026-09-06 Allison Schwartz Director Shares withheld for taxes / exercise cost 34 $386.11 $13.1K Form 4
2026-09-06 Allison Schwartz Director Option exercise / conversion 92 — $0 Form 4
2026-09-05 Mehta Rajat Officer (EVP, GBL Commercial Operations) Option exercise / conversion (derivative) 1,370 — $0 Form 4
2026-09-05 Mehta Rajat Officer (EVP, GBL Commercial Operations) Option exercise / conversion (derivative) 456 — $0 Form 4
2026-09-05 Mehta Rajat Officer (EVP, GBL Commercial Operations) Shares withheld for taxes / exercise cost 504 $386.11 $194.6K Form 4
2026-09-05 Mehta Rajat Officer (EVP, GBL Commercial Operations) Option exercise / conversion 1,370 — $0 Form 4
2026-09-05 Mehta Rajat Officer (EVP, GBL Commercial Operations) Shares withheld for taxes / exercise cost 233 $386.11 $90.0K Form 4
2026-09-05 Mehta Rajat Officer (EVP, GBL Commercial Operations) Option exercise / conversion 456 — $0 Form 4
2026-09-05 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Option exercise / conversion (derivative) 1,027 — $0 Form 4
2026-09-05 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Shares withheld for taxes / exercise cost 369 $386.11 $142.5K Form 4
2026-09-05 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Option exercise / conversion 1,027 — $0 Form 4
2026-09-05 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Option exercise / conversion (derivative) 685 — $0 Form 4
2026-09-05 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Shares withheld for taxes / exercise cost 246 $386.11 $95.0K Form 4
2026-09-05 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Option exercise / conversion 685 — $0 Form 4
2026-09-05 EVRAN SEDAT Officer (EVP, Global Supply Chain) Option exercise / conversion (derivative) 1,027 — $0 Form 4
2026-09-05 EVRAN SEDAT Officer (EVP, Global Supply Chain) Shares withheld for taxes / exercise cost 329 $386.11 $127.0K Form 4
2026-09-05 EVRAN SEDAT Officer (EVP, Global Supply Chain) Option exercise / conversion 1,027 — $0 Form 4
2026-09-05 DiVincenzo Jonathan P. Officer (President & COO) Option exercise / conversion (derivative) 1,712 — $0 Form 4
2026-09-05 DiVincenzo Jonathan P. Officer (President & COO) Shares withheld for taxes / exercise cost 668 $386.11 $257.9K Form 4
2026-09-05 DiVincenzo Jonathan P. Officer (President & COO) Option exercise / conversion 1,712 — $0 Form 4
2026-09-05 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Option exercise / conversion (derivative) 1,370 — $0 Form 4
2026-09-05 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Shares withheld for taxes / exercise cost 559 $386.11 $215.8K Form 4
2026-09-05 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Option exercise / conversion 1,370 — $0 Form 4
2026-09-05 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Option exercise / conversion (derivative) 4,109 — $0 Form 4
2026-09-05 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Shares withheld for taxes / exercise cost 2,876 $386.11 $1.11M Form 4
2026-09-05 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Option exercise / conversion 4,109 — $0 Form 4
2026-09-05 BARRY JAMES Officer (EVP, President, LSG) Option exercise / conversion (derivative) 1,027 — $0 Form 4
2026-09-05 BARRY JAMES Officer (EVP, President, LSG) Shares withheld for taxes / exercise cost 369 $386.11 $142.5K Form 4
2026-09-05 BARRY JAMES Officer (EVP, President, LSG) Option exercise / conversion 1,027 — $0 Form 4
2026-09-05 Allison Schwartz Director Option exercise / conversion (derivative) 228 — $0 Form 4
2026-09-05 Allison Schwartz Director Shares withheld for taxes / exercise cost 82 $386.11 $31.7K Form 4
2026-09-05 Allison Schwartz Director Option exercise / conversion 228 — $0 Form 4
2026-09-04 Mehta Rajat Officer (EVP, GBL Commercial Operations) Grant / award / vesting (derivative) 4,601 — $0 Form 4
2026-09-04 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Grant / award / vesting (derivative) 4,313 — $0 Form 4
2026-09-04 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Grant / award / vesting (derivative) 2,876 — $0 Form 4
2026-09-04 EVRAN SEDAT Officer (EVP, Global Supply Chain) Grant / award / vesting (derivative) 4,026 — $0 Form 4
2026-09-04 DiVincenzo Jonathan P. Officer (President & COO) Grant / award / vesting (derivative) 6,326 — $0 Form 4
2026-09-04 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Grant / award / vesting (derivative) 6,326 — $0 Form 4
2026-09-04 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Grant / award / vesting (derivative) 17,251 — $0 Form 4
2026-09-04 BARRY JAMES Officer (EVP, President, LSG) Grant / award / vesting (derivative) 4,313 — $0 Form 4
2026-09-04 Allison Schwartz Director Grant / award / vesting (derivative) 719 — $0 Form 4
2026-09-01 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Option exercise / conversion (derivative) 3,005 — $0 Form 4
2026-09-01 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Option exercise / conversion (derivative) 2,082 — $0 Form 4
2026-09-01 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Shares withheld for taxes / exercise cost 2,336 $380.96 $889.9K Form 4
2026-09-01 SCHWARTZ NORMAN D Director, Officer (Chairman & CEO), 10% owner Option exercise / conversion 5,087 — $0 Form 4
2026-09-01 BARRY JAMES Officer (EVP, President, LSG) Option exercise / conversion (derivative) 251 — $0 Form 4
2026-09-01 BARRY JAMES Officer (EVP, President, LSG) Option exercise / conversion (derivative) 174 — $0 Form 4
2026-09-01 BARRY JAMES Officer (EVP, President, LSG) Shares withheld for taxes / exercise cost 154 $380.96 $58.7K Form 4
2026-09-01 BARRY JAMES Officer (EVP, President, LSG) Option exercise / conversion 425 — $0 Form 4
2026-09-01 Allison Schwartz Director Option exercise / conversion (derivative) 75 — $0 Form 4
2026-09-01 Allison Schwartz Director Option exercise / conversion (derivative) 42 — $0 Form 4
2026-09-01 Allison Schwartz Director Shares withheld for taxes / exercise cost 43 $380.96 $16.4K Form 4
2026-09-01 Allison Schwartz Director Option exercise / conversion 117 — $0 Form 4
2026-07-25 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Option exercise / conversion (derivative) 246 — $0 Form 4
2026-07-25 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Shares withheld for taxes / exercise cost 89 $314.46 $28.0K Form 4
2026-07-25 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Option exercise / conversion 246 — $0 Form 4
2026-05-11 ENGELHARDT EVA ANETTE Officer (EVP, President, CDG) Open-market sale 550 $246.54 $135.6K Form 4
2026-04-24 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Option exercise / conversion (derivative) 186 — $0 Form 4
2026-04-24 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Shares withheld for taxes / exercise cost 77 $287.84 $22.2K Form 4
2026-04-24 ENLOE COURTNEY C Officer (EVP, General Counsel & Sec) Option exercise / conversion 186 — $0 Form 4
2026-04-24 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Option exercise / conversion (derivative) 1,078 — $0 Form 4
2026-04-24 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Shares withheld for taxes / exercise cost 420 $287.84 $120.9K Form 4
2026-04-24 Lakkaraju Roop Kalyan Officer (EVP, Chief Financial Officer) Option exercise / conversion 1,078 — $0 Form 4
2026-04-21 PINKSTON ARNOLD A Director Option exercise / conversion (derivative) 407 — $0 Form 4
2026-04-21 PINKSTON ARNOLD A Director Grant / award / vesting (derivative) 369 — $0 Form 4
2026-04-21 PINKSTON ARNOLD A Director Option exercise / conversion 407 — $0 Form 4
2026-04-21 EDWARDS JEFFREY L Director Option exercise / conversion (derivative) 407 — $0 Form 4
2026-04-21 EDWARDS JEFFREY L Director Grant / award / vesting (derivative) 369 — $0 Form 4
2026-04-21 EDWARDS JEFFREY L Director Option exercise / conversion 407 — $0 Form 4
2026-04-21 PEI MELINDA LITHERLAND Director Option exercise / conversion (derivative) 407 — $0 Form 4
2026-04-21 PEI MELINDA LITHERLAND Director Grant / award / vesting (derivative) 369 — $0 Form 4
2026-04-21 PEI MELINDA LITHERLAND Director Option exercise / conversion 407 — $0 Form 4
2026-04-21 Hinckley Greg K Director Option exercise / conversion (derivative) 407 — $0 Form 4
2026-04-21 Hinckley Greg K Director Grant / award / vesting (derivative) 369 — $0 Form 4
2026-04-21 Hinckley Greg K Director Option exercise / conversion 407 — $0 Form 4
2025-11-06 BARRY JAMES Officer (EVP, President, LSG) Open-market sale 700 $306.18 $214.3K Form 4
2025-10-24 DiVincenzo Jonathan P. Officer (President & COO) Option exercise / conversion (derivative) 1,869 — $0 Form 4
2025-10-24 DiVincenzo Jonathan P. Officer (President & COO) Shares withheld for taxes / exercise cost 950 $339.75 $322.8K Form 4
2025-10-24 DiVincenzo Jonathan P. Officer (President & COO) Option exercise / conversion 1,869 — $0 Form 4
2025-10-20 EVRAN SEDAT Officer (EVP, Global Supply Chain) Option exercise / conversion (derivative) 1,044 — $0 Form 4
2025-10-20 EVRAN SEDAT Officer (EVP, Global Supply Chain) Shares withheld for taxes / exercise cost 335 $321.90 $107.8K Form 4

Ask the chat about BIO's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Bio-Rad Laboratories (BIO).

Last updated 2026-09-06 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.